NEW YORK, March 26, 2015 /PRNewswire/ -- OTC Markets
Group Inc. (OTCQX: OTCM), operator of Open, Transparent and
Connected financial marketplaces, today announced CollPlant
Holdings Ltd. (Tel Aviv Stock Exchange: CLPT; OTCQX: CQPTY),
an Israel-based medical device
firm that is advancing regenerative medicine through cutting-edge
technology, has qualified to have its American Depositary Receipts
(ADRs) trade on the OTCQX® Best Marketplace.
Logo -
http://photos.prnewswire.com/prnh/20110118/MM31963LOGO
CollPlant begins trading today on OTCQX under the symbol
"CQPTY," where each ADR represents 100 ordinary shares. U.S.
investors can find current financial disclosure and Real-Time Level
2 quotes for the company on www.otcmarkets.com.
"We are pleased to welcome CollPlant to the family of
established, global and growing companies on OTCQX," said
R. Cromwell Coulson, President and
CEO of OTC Markets Group. "Trading on OTCQX will help the
company increase its exposure to U.S. investors through transparent
trading and convenient access to its news and financial
disclosure. We look forward to supporting CollPlant and its
shareholders in the U.S. market."
Yehiel Tal, CEO of CollPlant,
noted, "We are delighted to begin trading on the OTCQX marketplace.
Our innovative line of biomaterials currently under
development, including products for use in orthopedics, wound care
and general surgery, addresses large and growing, global markets.
This year, we expect to launch two of our three lead products
- Vergenix™STR (Soft Tissue Repair matrix) for treatment of
tendinopathy and Vergenix™FG (Flowable Gel) for treatment of wounds
- in Europe, and are concurrently
pursuing clinical and commercialization plans in the U.S. and
elsewhere. As such, trading on OTCQX is a natural extension
of our growth goals."
BNY Mellon serves as CollPlant's Principal American Liaison
("PAL") on OTCQX, responsible for providing professional guidance
on OTCQX requirements.
CollPlant is a medical device firm established in 2004 focused
on advancing regenerative medicine through cutting-edge technology
designed to generate and process proprietary recombinant human
collagen (rhCollagen), among other patent-protected recombinant
proteins. CollPlant is developing a broad spectrum of biomaterials
for a wide variety of medical markets, including orthopedics, wound
healing, and general surgery. These include: Vergenix™STR
(Soft Tissue Repair Matrix), indicated for the treatment of
tendinopathy; Vergenix™FG (Flowable Gel) wound filler, for
treatment of acute and chronic wounds, and; Vergenix™BVF (Bone Void
Filler), indicated for spinal fusion procedures in posterolateral
approach. CollPlant's business model consists of its own
development and manufacturing of medical devices and their
commercialization and distribution, together with leading third
parties, alongside alliances with leading companies for joint
development, manufacturing and marketing of additional
products.
About OTC Markets Group Inc.
OTC Markets Group Inc.
(OTCQX: OTCM) operates Open, Transparent and Connected financial
marketplaces for 10,000 U.S. and global securities. Through
our OTC Link® ATS, we directly link a diverse network of
broker-dealers that provide liquidity and execution services for a
wide spectrum of securities. We organize these securities
into marketplaces to inform investors of opportunities and risks:
the OTCQX® Best Marketplace; the OTCQB® Venture Marketplace; and
the OTC Pink® Open Marketplace. Our data-driven platform
enables investors to easily trade through the broker of their
choice at the best possible price and empowers a broad range of
companies to improve the quality and availability of information
for their investors. To learn more about how we create better
informed and more efficient financial marketplaces, visit
www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and
SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
Saskia
Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428,
saskia@otcmarkets.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-collplant-holdings-to-otcqx-300056252.html
SOURCE OTC Markets Group Inc.